The Fred Hutchinson/University of Washington Cancer Consortium is a research collaboration comprising Fred Hutch and its strong collaborators: the University of Washington, Seattle Children's, and the Seattle Cancer Care Alliance. Formed in 2002, the Consortium is recognized as an NCI-designated Comprehensive Cancer Center through its dedication to developing research programs, faculty, and facilities that will lead to better approaches to prevention, diagnosis, and treatment of cancer.
The Consortium brings together over 650 faculty with interests in basic science, clinical and translational research, and public health sciences related to cancer.
Areas of Research Focus
The Consortium’s efforts hinge on five targeted areas of research expertise:
Molecular Basis of Cancer
Leverage Consortium expertise in cancer biology, computational biology, and epigenetics to advance cancer diagnostics and treatment.
Immunology & Transplantation
Build on the Consortium’s historical strength to focus on next generation immunotherapeutic treatments such as T cell immunotherapy and therapeutic vaccines.
Pathogen Associated Malignancies
Further our understanding of the role played by bacterial or viral agents in cancer and develop approaches to both prevention and therapy, as well as implement public health measures directed at eliminating pathogen associated malignancies.
Tumor Site-Specific Translational Research
Deepen our knowledge of the development and progression of individual tumor types and utilize our extensive laboratory and clinical insights to improve therapies.
Quantify and reduce the burden of cancer across the entire disease spectrum by building on the work ongoing in programs such as the Women’s Health Initiative and Hutchinson Institute for Cancer Outcomes Research (HICOR).
Serving Our Local, Regional and Global Communities
We are dedicated to improving the lives of cancer patients in our community and continue to conduct cancer research relevant to our Catchment Area, which is comprised of the 13 counties of Western Washington surrounding Seattle. Our Office of Community Outreach & Engagement (OCOE) is partnering with communities burdened disproportionately by cancer to understand and address their concerns about and barriers to cancer education, prevention, care, and clinical trials. Our Office of Education & Training aims to support youth exploration of biomedical sciences, particularly underrepresented minorities, as well as nurture trainees at all stages who are seeking careers in cancer research, through programming both locally and further away.
The Cancer Consortium also serves as the central node of a vast research network of more than 1000 research sites in over 70 countries, most notably the Uganda Cancer Institute in Kampala, Uganda. We aim to extend our scientific advances beyond borders, turning research data into research results.